ATMS Insider Trading Activity and SEC Form 4 Filings
ATMS insider trading summary
No open-market insider purchases or sales of Artemis Therapeutics, Inc. (ATMS) have been reported on SEC Form 4 in the past 12 months.
Latest ATMS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 18, 2018 | Gadi Peleg | Director | Sell | $47 (182 @ $0.26) |
| Oct 23, 2017 | Brian M Culley | Chief Executive Officer | Buy | $0 (25,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.